Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Manning

Showing results (131-140 of 133) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 133 results.
Global Spine Journal|February 1, 2020
MRI Radiological Predictors of Requiring Microscopic Lumbar Discectomy After Lumbar Disc HerniationChristopher G Varlotta, David H Ge, Nicholas Stekas, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 19, 2008
Antihyperalgesic effects of (R,E)-N-(2-hydroxy-2,3-dihydro-1H-inden-4-yl)-3-(2-(piperidin-1-yl)-4-(trifluoromethyl)phenyl)-acrylamide (AMG8562), a novel transient receptor potential vanilloid type 1 modulator that does not cause hyperthermia in ratsSonya G Lehto, Rami Tamir, Hong Deng, et al.
Journal of Medicinal Chemistry|April 6, 2007
Potent nonpeptide antagonists of the bradykinin B1 receptor: structure-activity relationship studies with novel diaminochroman carboxamidesKaustav Biswas, Aiwen Li, Jian Jeffrey Chen, et al.
Pageof 14

Showing results (131-140 of 133) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 133 results.
Global Spine Journal|February 1, 2020
MRI Radiological Predictors of Requiring Microscopic Lumbar Discectomy After Lumbar Disc HerniationChristopher G Varlotta, David H Ge, Nicholas Stekas, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 19, 2008
Antihyperalgesic effects of (R,E)-N-(2-hydroxy-2,3-dihydro-1H-inden-4-yl)-3-(2-(piperidin-1-yl)-4-(trifluoromethyl)phenyl)-acrylamide (AMG8562), a novel transient receptor potential vanilloid type 1 modulator that does not cause hyperthermia in ratsSonya G Lehto, Rami Tamir, Hong Deng, et al.
Journal of Medicinal Chemistry|April 6, 2007
Potent nonpeptide antagonists of the bradykinin B1 receptor: structure-activity relationship studies with novel diaminochroman carboxamidesKaustav Biswas, Aiwen Li, Jian Jeffrey Chen, et al.
Pageof 14